Alzheimer's Disease and Advanced Drug Delivery Strategies compiles under a single volume the most recent advances in drug delivery to the brain as related to AD treatment.
The editors recruited scientists from around the world to produce high quality chapters covering not only nanotechnological approaches, but also microsphere, niosomes, and liposomes. Among the topics covered are synthetic molecules, nobiletin, nose to brain delivery, natural biomaterials, cationic nanoformulations, dendrimers, microbubbles, and more.
Alzheimer's Disease and Advanced Drug Delivery Strategies is a complete reference for academic and corporate pharma researchers investigating targeted drug delivery to the brain. Medical & Health Sciences researchers would also benefit from understanding the strategies compiled under this volume.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iii 6. Contributors - p. xi 7. About the editors - p. xiii 8. Preface - p. xiii 9. Acknowledgments - p. xix 10. Chapter 1. Etiology, pathogenesis of Alzheimer's disease and amyloid beta hypothesis - p. 1 11. Chapter 2. Neuroinflammation in Alzheimer's disease - p. 13 12. Chapter 3. Recent updates in chemistry of Alzheimer's: Synthetic molecules - p. 33 13. Chapter 4. Blood brain barrier and its significance in drug delivery to brain in Alzheimer disease - p. 47 14. Chapter 5. Nose to brain delivery for the treatment of Alzheimer's disease - p. 61 15. Chapter 6. Amyloid cascade hypothesis, tau synthesis, and role of oxidative stress in AD - p. 73 16. Chapter 7. New biologicals and biomaterials in the therapy of Alzheimer's disease - p. 93 17. Chapter 8. Roles of nano medicine in diagnosis of Alzheimer's disease - p. 115 18. Chapter 9. Nanotechnology-based delivery for CRISPR-Cas 9 cargo in Alzheimer's disease - p. 139 19. Chapter 10. Liposomes as carrier for drug delivery in Alzheimer's disease - p. 153 20. Chapter 11. PLGA mediated drug delivery for Alzheimer's disease - p. 181 21. Chapter 12. Regulatory and ethical concerns in the use of nanomaterials - p. 197 22. Chapter 13. Symptoms and conventional treatments of Alzheimer's disease - p. 213 23. Chapter 14. Dendrimers in the management of Alzheimer's disease - p. 235 24. Chapter 15. Precision medicines for the treatment of Alzheimer's disease - p. 253 25. Chapter 16. Nanoformulations targeting Alzheimer's disease - p. 265 26. Chapter 17. Lipid nanoparticles in targeting Alzheimer's disease - p. 283 27. Chapter 18. Novel therapeutic approaches for targeting Alzheimer’s disease - p. 297 28. Chapter 19. Micro and nanoemulsion as drug carriers in Alzheimer's disease - p. 319 29. Chapter 20. Targeted nanotechnology-based formulations - p. 347 30. Chapter 21. Drug delivery for Alzheimer's disease using nanotechnology: Challenges and advancements - p. 361 31. Chapter 22. Current trends and updates in the treatment of Alzheimer's disease - p. 373 32. Chapter 23. Pharmacokinetics and pharmacodynamics of various novel formulations targeting Alzheimer's disease - p. 391 33. Chapter 24. Microbubbles-based drug delivery for antiAlzheimer's drugs - p. 403 34. Chapter 25. Neurotoxicity with the use of nanomaterials - p. 421 35. Chapter 26. Combinatorial therapy in Alzheimer's disease - p. 439 36. Index - p. 463
Alzheimer's Disease and Advanced Drug Delivery Strategies compiles under a single volume the most recent advances in drug delivery to the brain as related to AD treatment.
The editors recruited scientists from around the world to produce high quality chapters covering not only nanotechnological approaches, but also microsphere, niosomes, and liposomes. Among the topics covered are synthetic molecules, nobiletin, nose to brain delivery, natural biomaterials, cationic nanoformulations, dendrimers, microbubbles, and more.
Alzheimer's Disease and Advanced Drug Delivery Strategies is a complete reference for academic and corporate pharma researchers investigating targeted drug delivery to the brain. Medical & Health Sciences researchers would also benefit from understanding the strategies compiled under this volume.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iii 6. Contributors - p. xi 7. About the editors - p. xiii 8. Preface - p. xiii 9. Acknowledgments - p. xix 10. Chapter 1. Etiology, pathogenesis of Alzheimer's disease and amyloid beta hypothesis - p. 1 11. Chapter 2. Neuroinflammation in Alzheimer's disease - p. 13 12. Chapter 3. Recent updates in chemistry of Alzheimer's: Synthetic molecules - p. 33 13. Chapter 4. Blood brain barrier and its significance in drug delivery to brain in Alzheimer disease - p. 47 14. Chapter 5. Nose to brain delivery for the treatment of Alzheimer's disease - p. 61 15. Chapter 6. Amyloid cascade hypothesis, tau synthesis, and role of oxidative stress in AD - p. 73 16. Chapter 7. New biologicals and biomaterials in the therapy of Alzheimer's disease - p. 93 17. Chapter 8. Roles of nano medicine in diagnosis of Alzheimer's disease - p. 115 18. Chapter 9. Nanotechnology-based delivery for CRISPR-Cas 9 cargo in Alzheimer's disease - p. 139 19. Chapter 10. Liposomes as carrier for drug delivery in Alzheimer's disease - p. 153 20. Chapter 11. PLGA mediated drug delivery for Alzheimer's disease - p. 181 21. Chapter 12. Regulatory and ethical concerns in the use of nanomaterials - p. 197 22. Chapter 13. Symptoms and conventional treatments of Alzheimer's disease - p. 213 23. Chapter 14. Dendrimers in the management of Alzheimer's disease - p. 235 24. Chapter 15. Precision medicines for the treatment of Alzheimer's disease - p. 253 25. Chapter 16. Nanoformulations targeting Alzheimer's disease - p. 265 26. Chapter 17. Lipid nanoparticles in targeting Alzheimer's disease - p. 283 27. Chapter 18. Novel therapeutic approaches for targeting Alzheimer’s disease - p. 297 28. Chapter 19. Micro and nanoemulsion as drug carriers in Alzheimer's disease - p. 319 29. Chapter 20. Targeted nanotechnology-based formulations - p. 347 30. Chapter 21. Drug delivery for Alzheimer's disease using nanotechnology: Challenges and advancements - p. 361 31. Chapter 22. Current trends and updates in the treatment of Alzheimer's disease - p. 373 32. Chapter 23. Pharmacokinetics and pharmacodynamics of various novel formulations targeting Alzheimer's disease - p. 391 33. Chapter 24. Microbubbles-based drug delivery for antiAlzheimer's drugs - p. 403 34. Chapter 25. Neurotoxicity with the use of nanomaterials - p. 421 35. Chapter 26. Combinatorial therapy in Alzheimer's disease - p. 439 36. Index - p. 463
